New patent for Therakind drug JYLAMVO

August 24, 2023 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for JYLAMVO Jylamvo is a drug marketed by Therakind and is included in one NDA. The generic ingredient in JYLAMVO is methotrexate. Additional details are available…

The post New patent for Therakind drug JYLAMVO appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.